58198-9751 : Lufenuron 46 mg / Milbemycin Oxime 2.3 mg / Praziquantel 22.8 mg Chewable Tablet [Sentinel Spectrum]
| NDC: | 58198-9751 |
| Labeler: | Novartis Animal Health Us, Inc. |
| Drug Name: | Sentinel Spectrum |
| Rev. Date: |
Appearance:
| Markings: | NA |
| Shapes: |
Oval |
| Colors: |
Brown |
| Size (mm): | 12 |
| Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. | |
Active Ingredients:
- Milbemycin Oxime
- Lufenuron
- Praziquantel
Inactive Ingredients:
- Brown Iron Oxide
- Sodium Chloride
- Water
- Glycerin
- Propylene Glycol
- Butylated Hydroxyanisole
- Propyl Gallate
- Citric Acid Monohydrate
- Beef
- Sucrose
- Starch, Corn
Related Products:
Based on records with the same trade name.- 58198-9752 Lufenuron 115 mg / Milbemycin Oxime 5.75 mg / Praziquantel 57 mg Chewable Tablet [Sentinel Spectrum] by Novartis Animal Health Us, Inc.
- 58198-9753 Lufenuron 230 mg / Milbemycin Oxime 11.5 mg / Praziquantel 114 mg Chewable Tablet [Sentinel Spectrum] by Novartis Animal Health Us, Inc.
- 58198-9754 Lufenuron 460 mg / Milbemycin Oxime 23 mg / Praziquantel 228 mg Chewable Tablet [Sentinel Spectrum] by Novartis Animal Health Us, Inc.
NDC QR Code
Scan the QR code below to easily reference this data in the future:
< Prev: 58198-8402Next: 58198-9752 >
Related Discussions:
Praziquantel not treating Bilhazia
I was diagnosed with Schistosomiasis. Please, I need a total cure for this. I've been taking Praziquantel for years ...
I was diagnosed with Schistosomiasis. Please, I need a total cure for this. I've been taking Praziquantel for years ...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.
Brown